The intervention by a senior FDA official in a product decision is a highly unusual action.
Related Posts
Opioid deaths rose 50 percent during the pandemic. In these places, they fell.
- admin
- June 27, 2024
- 0
A federal plan to promote treatment and distribute overdose reversal drugs showed promise. Communities are trying to keep it going.
Top Senate Republican says PEPFAR program in jeopardy
- admin
- January 17, 2025
- 0
Foreign Affairs Relations Chair Jim Risch said money from the AIDS relief program paid for abortions.
‘No one’s coming to save us’: Abortion campaigns scramble for limited cash
- admin
- February 20, 2024
- 0
The scramble is pitting abortion-rights supporters in states with near-total bans against those in states where abortion is legal but under threat against those in […]
